Tag: CG-806

September 27, 2018

Aptose Biosciences and CrystalGenomics Announce Issuance of European Patent for CG-806

Aptose Biosciences (NASDAQ:APTO, TSX:APS), today announced that the European Patent Office has issued European Patent No. EP2940014B1 for CG-806, a...
May 22, 2018

Aptose Provides Molecule Update and Q1 Financial Results

Aptose Bioscience is the only company with a small molecule in development without those toxicities for AML patients with its...